Basal Cell Carcinoma Epidemiology

​​​​​​Key Highlights

• According to the Skin Cancer Foundation, Basal Cell Carcinoma is the most common form of skin cancer. An estimated 3.6 million cases of Basal cell carcinoma are diagnosed in the US annually. More than 419,000 cases of skin cancer in the US each year are linked to indoor tanning, including about 245,000 basal cell carcinomas, 168,000 squamous cell carcinomas and 6,200 melanomas, Those who have ever tanned indoors have a 83% increased risk of developing squamous cell carcinoma and a 29% increased risk of developing basal cell carcinoma, Any history of indoor tanning increases the risk of developing basal cell carcinoma before age 40 by 69%. 

• Basal Cell Carcinoma epidemiology is segmented as Total Basal Cell Carcinoma Prevalent Cases, Total Basal Cell Carcinoma Nonmelanoma Prevalent cases, Basal Cell Carcinoma Subtype-specific Cases, Basal Cell Carcinoma Prevalent cases, and Basal Cell Carcinoma Stage-Specific Prevalent cases in the Basal Cell Carcinoma epidemiology report.

Request for Sample Report of  Basal Cell Carcinoma Epidemiology

DelveInsight's ‘Basal Cell Carcinoma Epidemiology Forecast — 2034’ report delivers an in-depth understanding of the disease, historical and forecasted Basal Cell Carcinoma epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.

Geography Covered

• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2021-2034

Basal Cell Carcinoma Epidemiology: Disease Understanding

The DelveInsight’s Basal Cell Carcinoma market report gives a thorough understanding of Basal Cell Carcinoma by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. The DelveInsight’s Basal Cell Carcinoma market report gives a thorough understanding of Basal Cell Carcinoma by including details such as disease definition, symptoms, causes, pathophysiology, diagnosis, and treatment. Basal Cell Carcinoma is the most common form of skin cancer and the most frequently occurring form of all cancers. Basal cell carcinoma mostly arises on sun-damaged skin and rarely develops on the mucous membranes or palms and soles. Basal cell carcinoma is usually a slow-growing tumor for which metastases are rare. Although rarely fatal, Basal cell carcinoma can be highly destructive and disfigure local tissues when treatment is inadequate or delayed. On clinical examination, Basal cell carcinoma usually appears as flesh- or pink-colored, pearly papules with overlying ulceration or telangiectatic vessels. Basal cell carcinoma occurs on the head or neck in the majority of cases, but can involve the trunk and extremities.

More than 26 different subtypes of Basal cell carcinoma, but the more common, distinctive, clinicopathologic types include: nodular, micronodular, superficial, morpheaform, infiltrative and fibroepithelial (also known as fibroepithelioma of Pinkus). Combinations of these types can occur as well. The majority of Basal cell carcinomas are amelanotic, but variable amounts of melanin may be present within these tumors.

Basal Cell Carcinoma Diagnosis

A skin biopsy is necessary for clinical confirmation of Basal cell carcinoma. A shave, punch, or excisional biopsy are all options, taking care to include some portion of the dermis in the specimen to differentiate between superficial and other invasive histologic subtypes of Basal cell carcinoma. Dermoscopy can be beneficial to the experienced clinician, aiding in the diagnosis of non-pigmented and pigmented Basal cell carcinomas.

The differential diagnosis of Basal cell carcinoma includes adnexal tumors with follicular, sweat gland, or sebaceous differentiation and certain types of Squamous cell carcinomas. Nodular Basal cell carcinoma may be confused with trichoblastoma or trichoepithelioma. Superficial Basal cell carcinoma may mimic some inflammatory dermatoses such as psoriasis and eczema. Morphea-like Basal cell carcinoma may be confused with a plaque of morphea or a scar. In these cases, histopathological helps to establish the diagnosis of Basal cell carcinoma.

Basal Cell Carcinoma Epidemiology 

The Basal Cell Carcinoma epidemiology section provides insights about historical and current Basal Cell Carcinoma patient pool and forecasted trends for individual seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

Key Findings

• According to the Skin Cancer Foundation, Basal Cell Carcinoma is the most common form of skin cancer. An estimated 3.6 million cases of Basal cell carcinoma are diagnosed in the US annually. More than 419,000 cases of skin cancer in the US each year are linked to indoor tanning, including about 245,000 basal cell carcinomas, 168,000 squamous cell carcinomas and 6,200 melanomas, Those who have ever tanned indoors have a 83% increased risk of developing squamous cell carcinoma and a 29% increased risk of developing basal cell carcinoma, Any history of indoor tanning increases the risk of developing basal cell carcinoma before age 40 by 69%. 

• The disease epidemiology covered in the report provides historical as well as forecasted Basal Cell Carcinoma epidemiology [segmented as Total Prevalent Cases of Basal Cell Carcinoma, Total Nonmelanoma Prevalent cases, Subtype-specific Cases of Basal Cell Carcinoma, Basal Cell Carcinoma Prevalent cases, and Stage-Specific Prevalent cases of Basal Cell Carcinoma] in the 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2021 to 2034.

Country Wise- Basal Cell Carcinoma Epidemiology

This section provides glimpse of the Basal Cell Carcinoma epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.

KOL- Views

To keep up with the current Basal Cell Carcinoma patient pool and forecasted trend, we take KOLs and SMEs ' opinions working in the Basal Cell Carcinoma domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate the patient pool and forecasted trend.

Learn how the therapeutic market will evolve and grow in the coming years: Basal Cell Carcinoma Market
 

Scope of the Basal Cell Carcinoma Epidemiology Report

• The report covers the descriptive overview of Basal Cell Carcinoma, explaining their causes, symptoms, pathophysiology, and genetic basis
• The report provides insight into the 7MM historical and forecasted patient pool covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan
• The report assesses the disease risk and burden and highlights the unmet needs of Basal Cell Carcinoma
• The report helps to recognize the growth opportunities in the 7MM concerning the patient population
• The report provides the segmentation of the disease epidemiology for 7MM by Total Prevalent Cases of Basal Cell Carcinoma, Total Nonmelanoma Prevalent cases, Subtype-specific Cases of Basal Cell Carcinoma, Basal Cell Carcinoma Prevalent cases, and Stage-Specific Prevalent cases of Basal Cell Carcinoma

Basal Cell Carcinoma Epidemiology Report Highlights

• The companies and academics are working to assess challenges and seek opportunities that could influence Basal Cell Carcinoma R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition      
• A better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for Basal Cell Carcinoma 
• Our in-depth analysis of the pipeline assets across different stages of development (Phase III and Phase II), different emerging trends, and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities

Basal Cell Carcinoma Report Insights

• Patient Population
• Therapeutic Approaches

Basal Cell Carcinoma Report Key Strengths

• 11 Years Forecast
• 7MM Coverage
• Basal Cell Carcinoma Epidemiology Segmentation

Basal Cell Carcinoma Report Assessment

• Disease Understanding
• Current Diagosis Practices and Guidelines
• Epidemiology Trends

Key Questions

Epidemiology Insights:

• What are the disease risk, burden, and regional/ethnic differences of Basal Cell Carcinoma?
• What are the key factors driving the epidemiology trend for seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
• What is the historical Basal Cell Carcinoma patient pool in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
• What would be the forecasted patient pool of Basal Cell Carcinoma in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
• Where will be the growth opportunities in the 7MM concerning the patient population about Basal Cell Carcinoma?
• Out of all 7MM countries, which country would have the highest prevalent population of Basal Cell Carcinoma during the forecast period (2025-2034)?
• At what CAGR the patient population is expected to grow by 7MM during the forecast period (2025-2034)?

Reasons to buy

• The report will help in developing business strategies by understanding trends shaping and driving the Basal Cell Carcinoma Disease market
• To understand the future market competition in the Basal Cell Carcinoma Disease market and Insightful review of the key market drivers and barriers
• Organize sales and marketing efforts by identifying the best opportunities for Basal Cell Carcinoma Disease in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom), and Japan
• Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
• Organize sales and marketing efforts by identifying the best opportunities for the Basal Cell Carcinoma Disease market
• To understand the future market competition in the Basal Cell Carcinoma Disease market